Abiraterone plus prednisone improves survival in metastatic castration-resistant prostate cancer

Asian J Androl. 2011 Nov;13(6):785-6. doi: 10.1038/aja.2011.113. Epub 2011 Aug 22.

Authors

Scott T Tagawa¹, Himisha Beltran

Affiliation

¹ Department of Medicine, Weill Cornell Medical College, Weill Cornell Cancer Center, New York, NY 10065, USA. stt2007@med.cornell.edu

No abstract available

MeSH terms

Androstenes
Androstenols / administration & dosage
Antineoplastic Combined Chemotherapy Protocols / administration & dosage
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Enzyme Inhibitors / administration & dosage
Humans
Male
Neoplasm Metastasis
Orchiectomy*
Prednisone / administration & dosage
Prostatic Neoplasms / drug therapy*
Prostatic Neoplasms / pathology
Prostatic Neoplasms / surgery

Substances

Androstenes
Androstenols
Enzyme Inhibitors
abiraterone
Prednisone